O	O	O	0	9	PPARalpha	PPARalpha	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	10	20	activators	activator	I-NP	NNS	O	3	SUB	O
O	O	O	21	28	inhibit	inhibit	B-VP	VBP	O	0	ROOT	O
O	O	O	29	37	cytokine	cytokine	B-NP	NN	B-protein	6	AMOD	B-protein
O	O	O	37	38	-	-	O	HYPH	O	4	P	O
O	O	O	38	45	induced	induce	B-NP	VBN	O	13	NMOD	O
T1	B-Protein	B-Protein	46	54	vascular	vascular	I-NP	JJ	B-protein	13	NMOD	B-protein
T1	I-Protein	I-Protein	55	59	cell	cell	I-NP	NN	I-protein	13	NMOD	I-protein
T1	I-Protein	I-Protein	60	68	adhesion	adhesion	I-NP	NN	I-protein	13	NMOD	I-protein
T1	I-Protein	I-Protein	69	77	molecule	molecule	I-NP	NN	I-protein	13	NMOD	I-protein
T1	I-Protein	I-Protein	77	78	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T1	I-Protein	I-Protein	78	79	1	1	I-NP	CD	I-protein	13	NMOD	I-protein
O	O	O	80	90	expression	expression	I-NP	NN	O	3	OBJ	O
O	O	O	91	93	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	94	99	human	human	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	O	100	111	endothelial	endothelial	I-NP	JJ	I-cell_type	17	NMOD	I-cell_type
O	O	O	112	117	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	O	117	118	.	.	O	.	O	3	P	O

O	O	O	120	130	BACKGROUND	BACKGROUND	B-NP	NN	O	14	VMOD	O
O	O	O	130	131	:	:	O	:	O	14	P	O
O	O	O	132	140	Adhesion	Adhesion	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	141	149	molecule	molecule	I-NP	NN	I-protein	5	NMOD	I-protein
O	O	O	150	160	expression	expression	I-NP	NN	O	14	SUB	O
O	O	O	161	163	on	on	B-PP	IN	O	5	NMOD	O
O	O	O	164	167	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	168	179	endothelial	endothelial	I-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	O	180	184	cell	cell	I-NP	NN	I-cell_type	13	NMOD	I-cell_type
O	O	O	185	186	(	(	O	(	O	12	DEP	O
O	O	O	186	188	EC	EC	B-NP	NN	B-cell_type	12	DEP	B-cell_type
O	O	O	188	189	)	)	O	)	O	9	NMOD	O
O	O	O	190	197	surface	surface	B-NP	NN	O	6	PMOD	O
O	O	O	198	200	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	201	209	critical	critical	B-ADJP	JJ	O	14	PRD	O
O	O	O	210	213	for	for	B-PP	IN	O	15	AMOD	O
O	O	O	214	223	leukocyte	leukocyte	B-NP	NN	O	18	NMOD	O
O	O	O	224	235	recruitment	recruitment	I-NP	NN	O	16	PMOD	O
O	O	O	236	238	to	to	B-PP	TO	O	18	NMOD	O
O	O	O	239	254	atherosclerotic	atherosclerotic	B-NP	JJ	O	21	NMOD	O
O	O	O	255	262	lesions	lesion	I-NP	NNS	O	19	PMOD	O
O	O	O	262	263	.	.	O	.	O	14	P	O

O	O	O	264	270	Better	Good	B-NP	JJR	O	2	NMOD	O
O	O	O	271	284	understanding	understanding	I-NP	NN	O	11	SUB	O
O	O	O	285	287	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	288	303	transcriptional	transcriptional	B-NP	JJ	O	5	NMOD	O
O	O	O	304	314	regulation	regulation	I-NP	NN	O	3	PMOD	O
O	O	O	315	317	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	318	326	adhesion	adhesion	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	327	336	molecules	molecule	I-NP	NNS	I-protein	6	PMOD	I-protein
O	O	O	337	339	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	340	343	ECs	EC	B-NP	NNS	B-cell_type	9	PMOD	B-cell_type
O	O	O	344	347	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	348	355	provide	provide	I-VP	VB	O	11	VC	O
O	O	O	356	365	important	important	B-NP	JJ	O	14	NMOD	O
O	O	O	366	373	insight	insight	I-NP	NN	O	12	OBJ	O
O	O	O	374	378	into	into	B-PP	IN	O	14	NMOD	O
O	O	O	379	385	plaque	plaque	B-NP	NN	O	17	NMOD	O
O	O	O	386	395	formation	formation	I-NP	NN	O	15	PMOD	O
O	O	O	395	396	.	.	O	.	O	11	P	O

T2	B-Protein	B-Protein	397	407	Peroxisome	Peroxisome	B-NP	NN	B-protein	5	NMOD	B-protein
T2	I-Protein	I-Protein	408	420	proliferator	proliferator	I-NP	NN	I-protein	5	NMOD	I-protein
T2	I-Protein	I-Protein	420	421	-	-	B-VP	HYPH	I-protein	5	P	I-protein
T2	I-Protein	I-Protein	421	430	activated	activate	B-NP	VBN	I-protein	5	NMOD	I-protein
T2	I-Protein	I-Protein	431	439	receptor	receptor	I-NP	NN	I-protein	13	NMOD	I-protein
T2	I-Protein	I-Protein	439	440	-	-	O	HYPH	O	7	P	O
T2	I-Protein	I-Protein	440	445	alpha	alpha	B-NP	SYM	O	13	NMOD	O
O	O	O	446	447	(	(	O	(	O	10	DEP	O
T3	B-Protein	B-Protein	447	456	PPARalpha	PPARalpha	B-NP	NN	B-protein	10	DEP	B-protein
O	O	O	456	457	)	)	O	)	O	7	VMOD	O
O	O	O	457	458	,	,	O	,	O	13	P	O
O	O	O	459	460	a	a	B-NP	DT	O	13	NMOD	O
O	O	O	461	467	member	member	I-NP	NN	O	20	SUB	O
O	O	O	468	470	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	471	474	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	475	482	nuclear	nuclear	I-NP	JJ	B-protein	18	NMOD	B-protein
O	O	O	483	491	receptor	receptor	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	492	498	family	family	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	O	498	499	,	,	O	,	O	13	P	O
O	O	O	500	509	regulates	regulate	B-VP	VBZ	O	0	ROOT	O
O	O	O	510	514	gene	gene	B-NP	NN	O	22	NMOD	O
O	O	O	515	525	expression	expression	I-NP	NN	O	20	OBJ	O
O	O	O	526	528	in	in	B-PP	IN	O	20	VMOD	O
O	O	O	529	537	response	response	B-NP	NN	O	32	NMOD	O
O	O	O	538	540	to	to	B-PP	TO	O	24	NMOD	O
O	O	O	541	548	certain	certain	B-NP	JJ	O	28	NMOD	O
O	O	O	549	554	fatty	fatty	I-NP	JJ	O	28	NMOD	O
O	O	O	555	560	acids	acid	I-NP	NNS	O	25	PMOD	O
O	O	O	561	564	and	and	O	CC	O	32	NMOD	O
O	O	O	565	571	fibric	fibric	B-NP	JJ	O	32	NMOD	O
O	O	O	572	576	acid	acid	I-NP	NN	O	32	NMOD	O
O	O	O	577	588	derivatives	derivative	I-NP	NNS	O	23	PMOD	O
O	O	O	588	589	.	.	O	.	O	20	P	O

O	O	O	590	593	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	594	601	present	present	I-NP	JJ	O	3	NMOD	O
O	O	O	602	607	study	study	I-NP	NN	O	4	SUB	O
O	O	O	608	620	investigated	investigate	B-VP	VBD	O	0	ROOT	O
T4	B-Protein	B-Protein	621	630	PPARalpha	PPARalpha	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	631	641	expression	expression	I-NP	NN	O	12	NMOD	O
O	O	O	642	644	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	645	650	human	human	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	O	651	654	ECs	EC	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	O	655	658	and	and	O	CC	O	12	NMOD	O
O	O	O	659	664	their	their	B-NP	PRP$	O	12	NMOD	O
O	O	O	665	675	regulation	regulation	I-NP	NN	O	4	OBJ	O
O	O	O	676	678	of	of	B-PP	IN	O	12	NMOD	O
T5	B-Protein	B-Protein	679	687	vascular	vascular	B-NP	JJ	B-protein	17	NMOD	B-protein
T5	I-Protein	I-Protein	688	692	cell	cell	I-NP	NN	I-protein	17	NMOD	I-protein
T5	I-Protein	I-Protein	693	701	adhesion	adhesion	I-NP	NN	I-protein	17	NMOD	I-protein
T5	I-Protein	I-Protein	702	710	molecule	molecule	I-NP	NN	I-protein	13	PMOD	I-protein
T5	I-Protein	I-Protein	710	711	-	-	B-NP	HYPH	O	19	P	O
T5	I-Protein	I-Protein	711	712	1	1	I-NP	CD	O	17	NMOD	O
O	O	O	713	714	(	(	O	(	O	24	DEP	O
T6	B-Protein	B-Protein	714	718	VCAM	VCAM	B-NP	NN	B-protein	22	NMOD	B-protein
T6	I-Protein	I-Protein	718	719	-	-	B-NP	HYPH	I-protein	24	DEP	I-protein
T6	I-Protein	I-Protein	719	720	1	1	I-NP	CD	I-protein	22	NMOD	I-protein
O	O	O	720	721	)	)	O	)	O	17	NMOD	O
O	O	O	721	722	.	.	O	.	O	4	P	O

O	O	O	723	730	METHODS	METHODS	B-NP	NNS	O	3	NMOD	O
O	O	O	731	734	AND	AND	I-NP	CC	O	3	NMOD	O
O	O	O	735	742	RESULTS	RESULTS	I-NP	NNS	O	6	VMOD	O
O	O	O	742	743	:	:	O	:	O	6	P	O
O	O	O	744	764	Immunohistochemistry	Immunohistochemistry	B-NP	NN	O	6	SUB	O
O	O	O	765	773	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	O	774	778	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	O	779	784	human	human	B-NP	JJ	B-cell_type	11	NMOD	B-cell_type
O	O	O	785	792	carotid	carotid	I-NP	JJ	I-cell_type	11	NMOD	I-cell_type
O	O	O	793	799	artery	artery	I-NP	NN	I-cell_type	11	NMOD	I-cell_type
O	O	O	800	803	ECs	EC	I-NP	NNS	I-cell_type	12	SUB	I-cell_type
O	O	O	804	811	express	express	B-VP	VBP	O	7	SBAR	O
T7	B-Protein	B-Protein	812	821	PPARalpha	PPARalpha	B-NP	NN	B-protein	12	OBJ	B-protein
O	O	O	821	822	.	.	O	.	O	6	P	O

O	O	O	823	835	Pretreatment	Pretreatment	B-NP	NN	O	13	SUB	O
O	O	O	836	838	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	839	847	cultured	culture	B-NP	VBN	B-cell_type	5	NMOD	B-cell_type
O	O	O	848	853	human	human	I-NP	JJ	I-cell_type	5	NMOD	I-cell_type
O	O	O	854	857	ECs	EC	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	O	858	862	with	with	B-PP	IN	O	1	NMOD	O
O	O	O	863	866	the	the	B-NP	DT	O	12	NMOD	O
T8	B-Protein	B-Protein	867	876	PPARalpha	PPARalpha	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	877	887	activators	activator	I-NP	NNS	O	12	NMOD	O
O	O	O	888	899	fenofibrate	fenofibrate	I-NP	NN	O	12	NMOD	O
O	O	O	900	902	or	or	I-NP	CC	O	12	NMOD	O
O	O	O	903	910	WY14643	WY14643	I-NP	NN	O	6	PMOD	O
O	O	O	911	920	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
T9	B-Protein	B-Protein	921	924	TNF	TNF	B-NP	NN	B-protein	13	OBJ	B-protein
T9	I-Protein	I-Protein	924	925	-	-	O	HYPH	O	16	P	O
T9	I-Protein	I-Protein	925	930	alpha	alpha	O	SYM	O	17	P	O
O	O	O	930	931	-	-	O	HYPH	O	14	P	O
O	O	O	931	938	induced	induce	B-NP	VBN	O	14	NMOD	O
T10	B-Protein	B-Protein	939	943	VCAM	VCAM	I-NP	NN	B-protein	20	NMOD	B-protein
T10	I-Protein	I-Protein	943	944	-	-	B-NP	HYPH	I-protein	18	VMOD	I-protein
T10	I-Protein	I-Protein	944	945	1	1	I-NP	CD	I-protein	20	NMOD	I-protein
O	O	O	946	948	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	949	950	a	a	B-NP	DT	O	33	NMOD	O
O	O	O	951	955	time	time	I-NP	NN	O	33	NMOD	O
O	O	O	955	956	-	-	B-NP	HYPH	O	33	NMOD	O
O	O	O	957	960	and	and	I-NP	CC	O	33	NMOD	O
O	O	O	961	974	concentration	concentration	I-NP	NN	O	30	NMOD	O
O	O	O	974	975	-	-	I-NP	HYPH	O	30	NMOD	O
O	O	O	975	984	dependent	dependent	I-NP	JJ	O	30	NMOD	O
O	O	O	985	991	manner	manner	I-NP	NN	O	33	NMOD	O
O	O	O	991	992	,	,	O	,	O	33	P	O
O	O	O	993	995	an	an	B-NP	DT	O	33	NMOD	O
O	O	O	996	1002	effect	effect	I-NP	NN	O	22	PMOD	O
O	O	O	1003	1006	not	not	B-VP	RB	O	35	VMOD	O
O	O	O	1007	1011	seen	see	I-VP	VBN	O	33	NMOD	O
O	O	O	1012	1016	with	with	B-PP	IN	O	35	VMOD	O
T11	B-Protein	B-Protein	1017	1026	PPARgamma	PPARgamma	B-NP	NN	B-protein	38	NMOD	B-protein
O	O	O	1027	1037	activators	activator	I-NP	NNS	O	36	PMOD	O
O	O	O	1037	1038	.	.	O	.	O	13	P	O

O	O	O	1039	1043	Both	Both	B-NP	DT	O	3	NMOD	O
T12	B-Protein	B-Protein	1044	1053	PPARalpha	PPARalpha	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	1054	1064	activators	activator	I-NP	NNS	O	4	SUB	O
O	O	O	1065	1074	decreased	decrease	B-VP	VBD	O	0	ROOT	O
O	O	O	1075	1083	cytokine	cytokine	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	1083	1084	-	-	O	HYPH	O	5	P	O
O	O	O	1084	1091	induced	induce	B-NP	VBN	O	12	NMOD	O
T13	B-Protein	B-Protein	1092	1096	VCAM	VCAM	I-NP	NN	B-protein	12	NMOD	B-protein
T13	I-Protein	I-Protein	1096	1097	-	-	B-NP	HYPH	O	12	P	O
T13	I-Protein	I-Protein	1097	1098	1	1	I-NP	CD	O	12	NMOD	O
O	O	O	1099	1103	mRNA	mRNA	I-NP	NN	O	12	NMOD	O
O	O	O	1104	1114	expression	expression	I-NP	NN	O	4	OBJ	O
O	O	O	1115	1122	without	without	B-PP	IN	O	4	VMOD	O
O	O	O	1123	1131	altering	alter	B-VP	VBG	O	13	PMOD	O
O	O	O	1132	1135	its	its	B-NP	PRP$	O	19	NMOD	O
O	O	O	1136	1140	mRNA	mRNA	I-NP	NN	O	17	NMOD	O
O	O	O	1141	1145	half	half	I-NP	NN	O	19	NMOD	O
O	O	O	1145	1146	-	-	I-NP	HYPH	O	19	P	O
O	O	O	1146	1150	life	life	I-NP	NN	O	14	OBJ	O
O	O	O	1150	1151	.	.	O	.	O	4	P	O

O	O	O	1152	1161	Transient	Transient	B-NP	JJ	O	2	NMOD	O
O	O	O	1162	1174	transfection	transfection	I-NP	NN	O	15	SUB	O
O	O	O	1175	1177	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	1178	1188	deletional	deletional	B-NP	JJ	O	14	NMOD	O
T14	B-Protein	B-Protein	1189	1193	VCAM	VCAM	I-NP	NN	B-protein	4	NMOD	B-protein
T14	I-Protein	I-Protein	1193	1194	-	-	B-NP	HYPH	O	4	P	O
T14	I-Protein	I-Protein	1194	1195	1	1	I-NP	CD	B-DNA	9	NMOD	B-DNA
O	O	O	1196	1204	promoter	promoter	I-NP	NN	I-DNA	9	NMOD	I-DNA
O	O	O	1205	1215	constructs	construct	I-NP	NNS	I-DNA	4	NMOD	I-DNA
O	O	O	1216	1219	and	and	O	CC	O	14	NMOD	O
O	O	O	1220	1235	electrophoretic	electrophoretic	B-NP	JJ	O	14	NMOD	O
O	O	O	1236	1244	mobility	mobility	I-NP	NN	O	14	NMOD	O
O	O	O	1245	1250	shift	shift	I-NP	NN	O	14	NMOD	O
O	O	O	1251	1257	assays	assay	I-NP	NNS	O	3	PMOD	O
O	O	O	1258	1265	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1266	1270	that	that	B-SBAR	IN	O	15	VMOD	O
O	O	O	1271	1282	fenofibrate	fenofibrate	B-NP	NN	O	18	SUB	O
O	O	O	1283	1291	inhibits	inhibit	B-VP	VBZ	O	16	SBAR	O
T15	B-Protein	B-Protein	1292	1296	VCAM	VCAM	B-NP	NN	B-protein	22	NMOD	B-protein
T15	I-Protein	I-Protein	1296	1297	-	-	B-NP	HYPH	O	22	NMOD	O
T15	I-Protein	I-Protein	1297	1298	1	1	I-NP	CD	O	22	NMOD	O
O	O	O	1299	1312	transcription	transcription	I-NP	NN	O	18	OBJ	O
O	O	O	1313	1315	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	1316	1320	part	part	B-NP	NN	O	23	PMOD	O
O	O	O	1321	1323	by	by	B-PP	IN	O	18	VMOD	O
O	O	O	1324	1334	inhibiting	inhibit	B-VP	VBG	O	25	PMOD	O
T20	B-Entity	B-Entity	1335	1337	NF	NF	B-NP	NN	B-protein	29	NMOD	B-protein
T20	I-Entity	I-Entity	1337	1338	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
T20	I-Entity	I-Entity	1338	1344	kappaB	kappaB	I-NP	NN	I-protein	26	OBJ	I-protein
O	O	O	1344	1345	.	.	O	.	O	15	P	O

O	O	O	1346	1353	Finally	Finally	B-ADVP	RB	O	6	VMOD	O
O	O	O	1353	1354	,	,	O	,	O	6	P	O
T16	B-Protein	B-Protein	1355	1364	PPARalpha	PPARalpha	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	1365	1375	activators	activator	I-NP	NNS	O	6	SUB	O
O	O	O	1376	1389	significantly	significantly	B-ADVP	RB	O	6	VMOD	O
O	O	O	1390	1397	reduced	reduce	B-VP	VBD	O	0	ROOT	O
O	O	O	1398	1406	adhesion	adhesion	B-NP	NN	O	6	OBJ	O
O	O	O	1407	1409	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	1410	1414	U937	U937	B-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	O	1415	1420	cells	cell	I-NP	NNS	I-cell_line	8	PMOD	I-cell_line
O	O	O	1421	1423	to	to	B-PP	TO	O	7	NMOD	O
O	O	O	1424	1432	cultured	culture	B-NP	VBN	B-cell_type	14	NMOD	B-cell_type
O	O	O	1433	1438	human	human	I-NP	JJ	I-cell_type	14	NMOD	I-cell_type
O	O	O	1439	1442	ECs	EC	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	O	1442	1443	.	.	O	.	O	6	P	O

O	O	O	1444	1455	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	5	VMOD	O
O	O	O	1455	1456	:	:	O	:	O	5	P	O
O	O	O	1457	1462	Human	Human	B-NP	JJ	B-cell_type	4	NMOD	B-cell_type
O	O	O	1463	1466	ECs	EC	I-NP	NNS	I-cell_type	5	SUB	I-cell_type
O	O	O	1467	1474	express	express	B-VP	VBP	O	0	ROOT	O
T17	B-Protein	B-Protein	1475	1484	PPARalpha	PPARalpha	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	1484	1485	,	,	O	,	O	11	P	O
O	O	O	1486	1487	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	1488	1499	potentially	potentially	I-NP	RB	O	10	AMOD	O
O	O	O	1500	1509	important	important	I-NP	JJ	O	11	NMOD	O
O	O	O	1510	1519	regulator	regulator	I-NP	NN	O	5	OBJ	O
O	O	O	1520	1522	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	1523	1536	atherogenesis	atherogenesis	B-NP	NN	O	12	PMOD	O
O	O	O	1537	1544	through	through	B-PP	IN	O	5	VMOD	O
O	O	O	1545	1548	its	its	B-NP	PRP$	O	17	NMOD	O
O	O	O	1549	1564	transcriptional	transcriptional	I-NP	JJ	O	17	NMOD	O
O	O	O	1565	1572	control	control	I-NP	NN	O	14	PMOD	O
O	O	O	1573	1575	of	of	B-PP	IN	O	17	NMOD	O
T18	B-Protein	B-Protein	1576	1580	VCAM	VCAM	B-NP	NN	B-protein	23	NMOD	B-protein
T18	I-Protein	I-Protein	1580	1581	-	-	B-NP	HYPH	O	23	NMOD	O
T18	I-Protein	I-Protein	1581	1582	1	1	I-NP	CD	O	23	NMOD	O
O	O	O	1583	1587	gene	gene	I-NP	NN	O	23	NMOD	O
O	O	O	1588	1598	expression	expression	I-NP	NN	O	18	PMOD	O
O	O	O	1598	1599	.	.	O	.	O	5	P	O

O	O	O	1600	1604	Such	Such	B-NP	JJ	O	2	NMOD	O
O	O	O	1605	1613	findings	finding	I-NP	NNS	O	4	SUB	O
O	O	O	1614	1618	also	also	B-ADVP	RB	O	4	VMOD	O
O	O	O	1619	1623	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	1624	1636	implications	implication	B-NP	NNS	O	4	OBJ	O
O	O	O	1637	1646	regarding	regard	B-VP	VBG	O	5	NMOD	O
O	O	O	1647	1650	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1651	1659	clinical	clinical	I-NP	JJ	O	9	NMOD	O
O	O	O	1660	1663	use	use	I-NP	NN	O	6	PMOD	O
O	O	O	1664	1666	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1667	1672	lipid	lipid	B-NP	NN	O	14	NMOD	O
O	O	O	1672	1673	-	-	O	HYPH	O	11	P	O
O	O	O	1673	1681	lowering	lower	B-NP	VBG	O	14	NMOD	O
O	O	O	1682	1688	agents	agent	I-NP	NNS	O	10	PMOD	O
O	O	O	1688	1689	,	,	O	,	O	4	P	O
O	O	O	1690	1694	like	like	B-PP	IN	O	4	VMOD	O
O	O	O	1695	1701	fibric	fibric	B-NP	JJ	O	18	NMOD	O
O	O	O	1702	1707	acids	acid	I-NP	NNS	O	16	PMOD	O
O	O	O	1707	1708	,	,	O	,	O	18	P	O
O	O	O	1709	1714	which	which	B-NP	WDT	O	18	NMOD	O
O	O	O	1715	1718	can	can	B-VP	MD	O	20	SBAR	O
O	O	O	1719	1727	activate	activate	I-VP	VB	O	21	VC	O
T19	B-Protein	B-Protein	1728	1737	PPARalpha	PPARalpha	B-NP	NN	B-protein	22	OBJ	B-protein
O	O	O	1737	1738	.	.	O	.	O	4	P	O
